Loading organizations...
MTPConnect SA operates as an accelerated ecosystem intermediary, cultivating the healthtech sector across medtech, pharmaceuticals, biotechnology, and digital health within South Australia. The organization develops this environment through targeted strategic connections, comprehensive capacity building initiatives, and by fostering a culture conducive to innovation throughout the entire pipeline, from initial research discovery to the scaling of emerging companies.
MTPConnect, initially established by the Australian Government in 2015, extended its focused efforts to South Australia when the local government began supporting MTPConnect SA as a dedicated intermediary in 2022. This strategic decision was driven by the insight that a localized accelerator was essential to effectively cultivate and scale the state's burgeoning healthtech capabilities and to integrate them more fully into national and global innovation networks.
The organization serves a diverse range of stakeholders including innovators, entrepreneurs, multinational corporations, service providers, and governmental entities. MTPConnect SA's overarching vision is to position Adelaide as a global hub for medical technology, biotechnology, and pharmaceutical innovation, attracting international engagement and investment, while actively promoting the region's clinical trials ecosystem to accelerate economic activity and improve health outcomes.
South Australian Life Science Advancement Partnership has 1 tracked investment across 1 company. The latest tracked deal is $14.0M Series B in Reverse Medical in March 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 30, 2010 | Reverse Medical | $14.0M Series B | — | BioStar Ventures, Early Stage Partners, Emergent Medical Partners, Getz Brothers, MedFocus Funds, Nbgi Ventures, Wexford Capital |